Korean Mizmedi Hospital loses case over egg donation
Although California's CIRM suggests they have the egg donation issue under control, a recent case in South Korea shows the complexities of the egg donation problem in stem cell research. Roh Sung-il was head of Mizmedi Clinic and a co-author on Hwang Woo-Suk's now retracted paper in Science in the year 2005.
from the Korea Times:
The Seoul Central District Court ordered local fertility clinic Mizmedi Hospital to pay 60 million won to a woman who underwent ova extraction procedures for its failure to properly inform her about the potential risk of infertility.
The 52-year-old woman, a Korean-Japanese, filed a suit against Roh Sung-il, head of the clinic, along with stem cell scientist Hwang Woo-suk, claiming that she had not been informed about potential risks posed by the egg retrieval processes.
A panel of judges said that the clinic was believed to have intentionally failed to provide the proper information about potential risks to the woman during the processes, and conducted the procedure for other than stated purposes.
The woman, identified only by her family name Han, underwent an egg extraction procedure in 1998 after hearing about the success of Roh’s fertility clinic in artificial insemination. She failed to become pregnant.
She filed a 500 million won suit against the clinic along with the sperm provider.
Roh was once regarded as one of the fertility clinic specialists when Hwang and his co-authors published two separate papers in the U.S. journal ``Science’’ in 2004 and 2005, claiming the creation of stem cell lines from cloned human embryos. They would have been world-first achievements if the work was valid.
**
David Magnus is quoted on californiastemcellreport.blogspot:
We could, for example, do quality control activities that other industries have, such as taping some informed consent sessions to determine if that actual consent process does what it is supposed to do (the studies of this sort that have been done have found some problems that could be eliminated). We could also build in studies of the informed consent process into a lot of the research that gets conducted. At this point the CIRM guidelines are actually completely silent on issues that will arise in clinical trials.
The Korean judges found that the informed consent in Korea was deficient. If researchers are more concerned with obtaining eggs than with the well-being of the donors, this sort of lapse is apt to be repeated, whether in Korea or in the United States.
from the Korea Times:
The Seoul Central District Court ordered local fertility clinic Mizmedi Hospital to pay 60 million won to a woman who underwent ova extraction procedures for its failure to properly inform her about the potential risk of infertility.
The 52-year-old woman, a Korean-Japanese, filed a suit against Roh Sung-il, head of the clinic, along with stem cell scientist Hwang Woo-suk, claiming that she had not been informed about potential risks posed by the egg retrieval processes.
A panel of judges said that the clinic was believed to have intentionally failed to provide the proper information about potential risks to the woman during the processes, and conducted the procedure for other than stated purposes.
The woman, identified only by her family name Han, underwent an egg extraction procedure in 1998 after hearing about the success of Roh’s fertility clinic in artificial insemination. She failed to become pregnant.
She filed a 500 million won suit against the clinic along with the sperm provider.
Roh was once regarded as one of the fertility clinic specialists when Hwang and his co-authors published two separate papers in the U.S. journal ``Science’’ in 2004 and 2005, claiming the creation of stem cell lines from cloned human embryos. They would have been world-first achievements if the work was valid.
**
David Magnus is quoted on californiastemcellreport.blogspot:
We could, for example, do quality control activities that other industries have, such as taping some informed consent sessions to determine if that actual consent process does what it is supposed to do (the studies of this sort that have been done have found some problems that could be eliminated). We could also build in studies of the informed consent process into a lot of the research that gets conducted. At this point the CIRM guidelines are actually completely silent on issues that will arise in clinical trials.
The Korean judges found that the informed consent in Korea was deficient. If researchers are more concerned with obtaining eggs than with the well-being of the donors, this sort of lapse is apt to be repeated, whether in Korea or in the United States.
posted by Lawrence B. Ebert at 7:47 AM
0 Comments:
Post a Comment
<< Home